RT Journal Article
SR Electronic
T1 Adaptive short term COVID-19 prediction for India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.18.20156745
DO 10.1101/2020.07.18.20156745
A1 Jana, Shuvrangshu
A1 Ghose, Debasish
YR 2020
UL http://medrxiv.org/content/early/2020/07/21/2020.07.18.20156745.abstract
AB In this paper, a data-driven adaptive model for infection of COVID-19 is formulated to predict the confirmed total cases and active cases of an area over 4 weeks. The parameter of the model is always updated based on daily observations. It is found that the short term prediction of up to 3-4 weeks can be possible with good accuracy. Detailed analysis of predicted value and the actual value of confirmed total cases and active cases for India from 1st June to 3rd July is provided. Prediction over 7, 14, 21, 28 days has the accuracy about 0.73% ± 1.97%, 1.92% ± 2.95%, 4.34% ± 3.91%, 6.40% ± 9.26% of the actual value of confirmed total cases. Similarly, the 7, 14, 21, 28 days prediction has the accuracy about 1.24% ± 6.57%, 3.04% ± 10.00%, 6.33% ± 16.12%, 10.20% ± 24.14% of the actual value of confirmed active cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in open source.